Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Mar 3, 2025
Date Accepted: Jul 2, 2025

The final, peer-reviewed published version of this preprint can be found here:

Mobile Telehealth Intervention to Support Care Partners of Patients With Alzheimer Disease and Related Dementias (I-CARE 2): Protocol for a Randomized Effectiveness Clinical Trial

Hill JR, Gardner B, Rodriguez MJ, Golzarri-Arroyo L, Zoh RS, Boustani Z, Burnell J, Jordan EJ, Boustani M, Holden RJ

Mobile Telehealth Intervention to Support Care Partners of Patients With Alzheimer Disease and Related Dementias (I-CARE 2): Protocol for a Randomized Effectiveness Clinical Trial

JMIR Res Protoc 2025;14:e73387

DOI: 10.2196/73387

PMID: 40902155

PMCID: 12444222

Mobile Telehealth Intervention to Support Care Partners of Patients with Alzheimer’s Disease and Related Dementias (I-CARE 2): Study Protocol for a Randomized Effectiveness Clinical Trial

  • Jordan R. Hill; 
  • Bailey Gardner; 
  • Miriam J. Rodriguez; 
  • Lilian Golzarri-Arroyo; 
  • Roger S. Zoh; 
  • Zayn Boustani; 
  • Jacqueline Burnell; 
  • Evan J. Jordan; 
  • Malaz Boustani; 
  • Richard J. Holden

ABSTRACT

Background:

Nearly all people with Alzheimer’s disease and related dementias (ADRD) will experience behavioral and psychological symptoms of dementia (BPSD), which include symptoms such as agitation, wandering, delusions, and hallucinations. Care partners (a person, often a family member, who provides care and support to someone with ADRD) struggle to manage BPSD, and the management of these symptoms is a critical target for intervention research. Our team has developed a mobile telehealth intervention (Brain CareNotes) to help care partners manage BPSD through the support of a care coach, written and visual materials on developing care skills, and BPSD measurement and tracking.

Objective:

This article outlines a protocol for a randomized controlled trial of 160 care partners of patients with ADRD to test the effect Brain CareNotes on care partner burden and patient BPSD.

Methods:

Participants will be recruited from partner health systems in Indiana, via word-of-mouth, and through community outreach efforts. Participants will be randomly assigned to use either the Brain CareNotes mobile app intervention or an education-only mobile app control for 12 months. Data will be collected at baseline, 6-, and 12-months. Primary outcomes for this trial are 1) care partner burden, and 2) patient BPSD. Secondary and exploratory outcomes are care partner depressive symptoms, patient and care partner acute care utilization, intervention usability and acceptability, and intervention usage. The trial also collects patient and care partner demographics and measures care partner self-efficacy, care partner social support, patient ADRD severity and patient functional abilities.

Results:

I-CARE 2 was funded by the National Institute on Aging (1R01AG078234) in September 2022 and is funded through August 2027. As of March 2025, we have enrolled 159 participants and 42 have successfully completed the study.

Conclusions:

Brain CareNotes is a unique mobile intervention to support care partners in managing BPSD. Due to the scalability of mobile health interventions, if Brain CareNotes is shown to be effective in reducing caregiver burden and patient BPSD, it has the potential for widespread adoption to support many ADRD care partners. Clinical Trial: ClinicalTrials.gov NCT05733520; https://clinicaltrials.gov/study/NCT05733520


 Citation

Please cite as:

Hill JR, Gardner B, Rodriguez MJ, Golzarri-Arroyo L, Zoh RS, Boustani Z, Burnell J, Jordan EJ, Boustani M, Holden RJ

Mobile Telehealth Intervention to Support Care Partners of Patients With Alzheimer Disease and Related Dementias (I-CARE 2): Protocol for a Randomized Effectiveness Clinical Trial

JMIR Res Protoc 2025;14:e73387

DOI: 10.2196/73387

PMID: 40902155

PMCID: 12444222

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.